Edition:
United States

GW Pharmaceuticals PLC (GWPRF.PK)

GWPRF.PK on OTC Markets Group

9.74USD
10:49am EST
Change (% chg)

$0.49 (+5.30%)
Prev Close
$9.25
Open
$9.74
Day's High
$9.74
Day's Low
$9.74
Volume
324
Avg. Vol
3,113
52-wk High
$11.28
52-wk Low
$7.68

Chart for

About

GW Pharmaceuticals plc is a biopharmaceutical company focused on developing and commercializing therapeutics from its cannabinoid product platform in a range of disease areas. The Company's lead cannabinoid product candidate is Epidiolex, which is a liquid formulation of pure plant-derived cannabidiol (CBD). The Company offers... (more)
No analyst recommendations are available for .

Overall

Beta: 1.27
Market Cap(Mil.): £2,264.76
Shares Outstanding(Mil.): 25.37
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 185.06 15.80
EPS (TTM): -- -- --
ROI: -- -10.84 12.07
ROE: -- -39.67 16.02

Earnings vs. Estimates